RxAmerica's "New Drug Notification" is a weekly
communication to our customers keeping them abreast of the most
recent FDA drug approvals, new indications on existing drugs,
recently released dosage forms and strengths, newly approved
generics, and market withdrawls. This service enables our customers
to prepare for questions, budget impact, and potential utilization
from new drug entities and indications.
New Brand Drugs:
December 18, 2007 - KUVAN
October 8, 2007 - AZOR
August 15, 2007
- ENDOMETRIN
August 15, 2007
- SELZENTRY
June 19, 2007 -
LETAIRIS
June 19, 2007 -
NUVIGIL
June 13, 2007 -
TORISEL
May 31, 2007 - XYZAL
May 23, 2007 -
LYBREL
May 15, 2007 -
BROVANA
March 19, 2007 -
TYKERB
March 12, 2007 -
TEKTURNA
January 5, 2007 -
INVEGA
New Generic Drugs:
November 21, 2007 -
OFLOXACIN, GENERIC FLOXIN® OTIC
October 20, 2007 -
FAMCICLOVIR, GENERIC FAMVIR®
October 20, 2007 -
DEXMETHYLPHENIDATE, GENERIC FOCALIN®
October 20, 2007
- OXCARBAZEPINE, GENERIC TRILEPTAL®
September 27, 2007
- CICLOPIROX, GENERIC PENLAC™
September 11, 2007 - CARVEDILOL, GENERIC
COREG®
September 11, 2007
- VERAPAMIL, GENERIC VERELAN® PM
August 10, 2007
- METOPROLOL ER, GENERIC TOPROL® XL
July 16, 2007
- TERBINAFINE, GENERIC LAMISIL®
June 22, 2007 -
AMLODIPINE/BENAZEPRIL, GENERIC LOTREL®
May 14, 2007 -
CEFDINIR, GENERIC OMNICEF®
April 27, 2007 -
ZOLPIDEM, GENERIC AMBIEN®
April 2, 2007 -
AMLODIPINE, GENERIC NORVASC
February 20,
2007 - TRANDOLAPRIL, GENERIC MAVIK
January 25,
2007 - DITROPAN XL, GENERIC OXYBUTYNIN
Adobe Acrobat Reader is required to view PDF files. Get
Adobe Reader
